サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439710

眼インプラント - 世界市場の考察、競合情勢、市場予測（2030年）

Ocular Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
眼インプラント - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の眼インプラントの市場規模は、2023年に50億6,043万米ドル、2030年までに65億6,146万米ドルに達し、2024年～2030年の予測期間にCAGRで4.51％の成長が見込まれます。市場は、緑内障、白内障、老眼、近視などのさまざまな眼疾患の症例の増加、世界の老年人口の負担の増加、製品の安全性と生体適合性をさらに高める技術の進歩などの要因によって成長が見込まれており、予測期間（2024年～2030年）に市場の大きな収益成長が見込まれています。

眼インプラントの市場力学

眼インプラント市場の注目すべき促進要因の1つは、白内障、緑内障、老眼、近視などの眼疾患の有病率の上昇です。例えば、世界保健機関（WHO）（2023）によると、近視または遠視の有病者は世界で22億人という驚異的な数字に達しており、この有病者の半数近くが視力障害を予防できた可能性があるにもかかわらず、まだ対処されていません。同じ資料によると、2020年における未対処の白内障と緑内障の有病者は、それぞれ9,400万人と770万人です。また、近視や老眼などの屈折異常も今後増加するとされています。例えば、International Myopia Institute（2023）によると、現在、世界の30％が近視であり、2050年までに近視人口は50％に増加し、50億人に達すると言われています。前述の資料はさらに、近視は東アジアや東南アジアでより一般的であり、韓国、中国、日本などの国々では80％～90％の有病率があると述べています。老眼の場合、世界保健機関（WHO）がWorld Report on Vision（2019）で引用したデータによると、2018年に世界中で約18億件の老眼が発生しています。

さらに、白内障、加齢黄斑変性（AMD）、緑内障、糖尿病性網膜症、老眼などを含む複数の眼疾患を発症しやすい老年人口の増加が、眼インプラント市場をさらに加速させる見込みです。WHO（2023）が提供したデータによると、2020年に世界中で約10億人が60歳以上でした。上記の資料は、2050年までに60歳以上の老年人口が倍増し、約21億人になると予測しています。また、80歳以上の人口は2020年～2050年に3倍に増え、4億2,600万人に達すると推定されています。

しかし、プレミアムレンズの適用範囲の欠如や、外科手術や機器に伴う合併症が、眼インプラント市場の抑制要因になる可能性があります。

眼インプラント市場は、COVID-19感染の連鎖を断ち切るために必要な措置としてロックダウンが実施されたため、市場成長の短期的な後退が報告されました。COVID-19パンデミックにより、医療サービスや医療処置の大規模な再編成が行われました。多くの国では、COVID-19危機の間、ワークフローを合理化するために、救急医療の必要性に基づいて医療処置を分離し、選択的と見なされるさまざまな医療処置が中断されました。例えば2020年3月、American Academy of Ophthalmology（AAO）は眼科医に対し、すべての日常診療を中止し、救急患者のみに診療を限定するよう推奨しました。AAOはまた、現地の規制を遵守し、引き続き注意しながら臨床活動を行うことができると推奨しました。また、ロックダウン中は眼インプラントの調達が困難となり、眼内手術の手技が減少しました。そのため、製品需要は通常より減少しました。しかし、医療部門を含む産業全体の活動再開が眼インプラント市場を押し上げており、2024年～2030年の予測期間における成長を促進する見込みです。

眼インプラント市場のセグメント分析

眼インプラント市場のタイプセグメントでは、眼内レンズカテゴリが2022年に78%の最高の収益シェアを占めました。

これは、眼内レンズのさまざまな特性、技術的優位性、共同研究や規制当局の承認などの製品開発活動の増加に起因しています。

当レポートでは、世界の眼インプラント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 眼インプラント市場レポートのイントロダクション

第2章 眼インプラント市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 眼インプラント市場の主な要因の分析

  • 眼インプラント市場の促進要因
    • 白内障、緑内障、老眼、近視などの眼疾患の増加
    • 世界中での老年人口の負担の増大
    • 製品設計における技術の進歩
  • 眼インプラント市場の抑制要因と課題
    • 外科手術と機器に関連する合併症
    • プレミアムレンズの適用範囲の欠如
  • 眼インプラント市場の機会
    • 製品の安全性と生体適合性の向上
    • 先進の眼インプラントの開発の進行

第5章 眼インプラント市場のポーターのファイブフォース分析

第6章 眼インプラント市場に対するCOVID-19の影響分析

第7章 眼インプラント市場のレイアウト

  • タイプ別
    • 眼内レンズ
    • 角膜インプラント
    • 緑内障インプラント
    • 人工虹彩
    • その他
  • 材料別
    • 生分解性
    • 非生分解性
  • 用途別
    • 白内障
    • 緑内障手術
    • 眼形成
    • ドラッグデリバリー
    • 黄斑変性症
  • エンドユーザー別
    • 病院
    • 眼科クリニック
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 眼インプラント市場の企業と製品のプロファイル

  • Alcon
  • Johnson & Johnson Services Inc.
  • Bausch Health Companies Inc.
  • ZEISS International
  • Glaukos Corporation
  • AbbVie Inc.
  • MORCHER® GmbH
  • HumanOptics Holding AG
  • Alimera Sciences
  • Advanced Artificial Eyes
  • Erickson Laboratories
  • Midwest Eye Laboratories, Inc.
  • EyeYon
  • EyePoint Pharmaceuticals, Inc.
  • HOYA Corporation
  • SMR Ophthalmic Pvt. Ltd.
  • Gulden Ophthalmics
  • AJL Ophthalmic S.A.
  • KeraMed, Inc.
  • Innovia Medical

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Ocular Implants Market
  • Table 3: Ocular Implants Market in Global (2021-2030)
  • Table 4: Ocular Implants Market in Global by Type (2021-2030)
  • Table 5: Ocular Implants Market in Global by Material (2021-2030)
  • Table 6: Ocular Implants Market in Global by Application (2021-2030)
  • Table 7: Ocular Implants Market in Global by End User (2021-2030)
  • Table 8: Ocular Implants Market in Global by Geography (2021-2030)
  • Table 9: Ocular Implants Market in North America (2021-2030)
  • Table 10: Ocular Implants Market in North America by Country (2021-2030)
  • Table 11: Ocular Implants Market in the US (2021-2030)
  • Table 12: Ocular Implants Market in Canada (2021-2030)
  • Table 13: Ocular Implants Market in Mexico (2021-2030)
  • Table 14: Ocular Implants Market in Europe (2021-2030)
  • Table 15: Ocular Implants Market in Europe by Country (2021-2030)
  • Table 16: Ocular Implants Market in France (2021-2030)
  • Table 17: Ocular Implants Market in Germany (2021-2030)
  • Table 18: Ocular Implants Market in the United Kingdom (2021-2030)
  • Table 19: Ocular Implants Market in Italy (2021-2030)
  • Table 20: Ocular Implants Market in Spain (2021-2030)
  • Table 21: Ocular Implants Market in Rest of Europe (2021-2030)
  • Table 22: Ocular Implants Market in APAC (2021-2030)
  • Table 23: Ocular Implants Market in APAC by Country (2021-2030)
  • Table 24: Ocular Implants Market in China (2021-2030)
  • Table 25: Ocular Implants Market in Japan (2021-2030)
  • Table 26: Ocular Implants Market in India (2021-2030)
  • Table 27: Ocular Implants Market in Australia (2021-2030)
  • Table 28: Ocular Implants Market in South Korea (2021-2030)
  • Table 29: Ocular Implants Market in Rest of APAC (2021-2030)
  • Table 30: Ocular Implants Market in Rest of the World (2021-2030)
  • Table 31: Ocular Implants Market in RoW by Region (2021-2030)
  • Table 32: Ocular Implants Market in Middle East (2021-2030)
  • Table 33: Ocular Implants Market in Africa (2021-2030)
  • Table 34: Ocular Implants Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Ocular Implants Market
  • Figure 3: Ocular Implants Market in Global (2021-2030)
  • Figure 4: Ocular Implants Market in Global by Type (2021-2030)
  • Figure 5: Ocular Implants Market in Global by Material (2021-2030)
  • Figure 6: Ocular Implants Market in Global by Application (2021-2030)
  • Figure 7: Ocular Implants Market in Global by End User (2021-2030)
  • Figure 8: Ocular Implants Market in Global by Geography (2021-2030)
  • Figure 9: Ocular Implants Market in North America (2021-2030)
  • Figure 10: Ocular Implants Market in North America by Country (2021-2030)
  • Figure 11: Ocular Implants Market in the US (2021-2030)
  • Figure 12: Ocular Implants Market in Canada (2021-2030)
  • Figure 13: Ocular Implants Market in Mexico (2021-2030)
  • Figure 14: Ocular Implants Market in Europe (2021-2030)
  • Figure 15: Ocular Implants Market in Europe by Country (2021-2030)
  • Figure 16: Ocular Implants Market in France (2021-2030)
  • Figure 17: Ocular Implants Market in Germany (2021-2030)
  • Figure 18: Ocular Implants Market in the United Kingdom (2021-2030)
  • Figure 19: Ocular Implants Market in Italy (2021-2030)
  • Figure 20: Ocular Implants Market in Spain (2021-2030)
  • Figure 21: Ocular Implants Market in Rest of Europe (2021-2030)
  • Figure 22: Ocular Implants Market in APAC (2021-2030)
  • Figure 23: Ocular Implants Market in APAC by Country (2021-2030)
  • Figure 24: Ocular Implants Market in China (2021-2030)
  • Figure 25: Ocular Implants Market in Japan (2021-2030)
  • Figure 26: Ocular Implants Market in India (2021-2030)
  • Figure 27: Ocular Implants Market in Australia (2021-2030)
  • Figure 28: Ocular Implants Market in South Korea (2021-2030)
  • Figure 29: Ocular Implants Market in Rest of APAC (2021-2030)
  • Figure 30: Ocular Implants Market in Rest of the World (2021-2030)
  • Figure 31: Ocular Implants Market in RoW by Region (2021-2030)
  • Figure 32: Ocular Implants Market in Middle East (2021-2030)
  • Figure 33: Ocular Implants Market in Africa (2021-2030)
  • Figure 34: Ocular Implants Market in South America (2021-2030)
  • Figure 35: Ocular Implants Market Drivers
  • Figure 36: Ocular Implants Market Barriers
  • Figure 37: Ocular Implants Market Opportunities
  • Figure 38: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0554

Ocular Implants Market By Type (Intraocular Lenses, Corneal Implants, Glaucoma Implants, Artificial Iris, And Others) By Material (Biodegradable And Non-Biodegradable), By Application (Cataract, Glaucoma Surgery, Oculoplasty, Drug Delivery, Macular Degeneration, And Others), By End-User (Hospitals, Eye Speciality Clinics, And Ambulatory Surgical Centres) and by geography is estimated to register a growth at a remarkable CAGR forecast during 2024-2030 owing to surge in the cases of various eye disorders and growing burden of geriatric population globally

The global ocular implants market was valued at USD 5,060.43 million in 2023, growing at a CAGR of 4.51% during the forecast period from 2024 to 2030 to reach USD 6,561.46 million by 2030. The ocular implants market is slated to witness growth owing to factors such as a rise in the cases of various eye disorders like glaucoma, cataract, presbyopia, and myopia among others, escalating burden of the geriatric population globally, and the increasing technological advancements to further enhance product safety and biocompatibility is expected to result in appreciable revenue growth in the ocular implants market during the forecast period (2024-2030).

Ocular Implants Market Dynamics:

One of the noteworthy drivers of the ocular implant market is the rise in the prevalence of eye disorders such as cataracts, glaucoma, presbyopia, and myopia. For instance, according to the World Health Organization (2023), the prevalence of population having near or distance vision impairment stands at a staggering figure of 2.2 billion globally, with which almost half of the affected people could have prevented vision impairment, or the cases have not yet been addressed. According to the same source, the prevalence rate of unaddressed cataracts and glaucoma in the year 2020 were 94 million and 7.7 million respectively. The number of refractive errors such as myopia and presbyopia is also said to increase in the upcoming years. For example, as per the International Myopia Institute (2023), 30% of the world is currently myopic and by 2050, the number of myopic people is said to grow to 50%, accounting for five billion. The aforementioned source further stated that myopia is more prevalent in East and South East Asia where countries such as South Korea, China, and Japan have a prevalence of 80% to 90%. In the case of presbyopia, as per the data cited by the World Health Organization in their World Report on Vision (2019), presbyopia accounted for approximately 1.8 billion cases across the globe in the year 2018.

Additionally, the rising geriatric population prone to the development of multiple eye disorders including cataracts, age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and presbyopia, among others is further going to accelerate the ocular implants market. According to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The source mentioned above added by stating that by 2050, the elderly population aged 60 and above is expected to double in number representing about 2.1 billion people. Also, people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million.

However, the lack of coverage of premium lenses and complications associated with surgical procedures and devices may act as restraining factors for the ocular implant market.

The ocular implants market reported a short period of a setback in market growth due to the implementation of lockdown as necessary measures to break the chain of COVID-19 infection transmission. The COVID-19 pandemic resulted in the massive reorganization of healthcare services and the carrying out of medical procedures. Many countries segregated medical procedures based on the need for urgent medical care to streamline the workflow during the COVID-19 crisis and saw various medical procedures considered elective being suspended. For instance, in March 2020, the American Academy of Ophthalmology (AAO) recommended ophthalmologists to stop all routine activities and restrict their treatment only to urgent and emergent cases; the AAO also recommended that clinical activities could be performed with continued caution in compliance with local regulations. Furthermore, the procedures of intra-ocular surgeries decreased as it became difficult to procure ocular implants during the lockdown period. This led to a decrease in product demand from regular levels. However, the resumption of activities across industries including the healthcare sector has been uplifting the ocular implants market and will drive growth during the forecast period from 2024-2030.

Ocular Implants Market Segment Analysis:

Ocular Implants Market by Type (Intraocular Lenses, Corneal Implants, Glaucoma Implants, Artificial Iris, and Others), Material (Biodegradable and Non-biodegradable), Application (Cataract, Glaucoma Surgery, Oculoplasty, Drug Delivery, Macular Degeneration, and Others), End-user (Hospitals, Eye Speciality Clinics, Ambulatory Surgical Centres), Geography (North-America, Europe, Asia-Pacific, Rest of the World).

In the type segment of the ocular implants market, the intraocular lenses category held the highest revenue share of 78% in 2022.

This can be attributed to the various properties, technical advantages, and increasing product development activities such as collaborations and regulatory approvals of intraocular lenses during the given forecast period.

IOLs are an excellent alternative to the excimer laser procedure (LASIK), they also eliminate the need for glasses or contact lenses post-surgery for most patients and the cataract will not return, as the lens has been removed.

IOLs such as aspheric IOLs eliminate the positive spherical aberration and offer patients improved contrast sensitivity, enhanced functional vision, and superior night driving ability.

Multifocal IOLs restore visual function and allow spectacle independence after their implantation with great levels of patient satisfaction and require less or no additional care or routine replacement.

Also, the toric IOLs are a type of monofocal IOL that helps correct corneal astigmatism of 1 D or more in cases undergoing cataract surgery and achieve spectacle independence for distance vision. For example, Auroflex Toric developed by Aurolab offers the perceivable benefit of superior quality vision for a patient with corneal astigmatism.

Extended Depth of Focus (EDOF or EDF), or Extended Range of Vision, is a new technology that has recently emerged in the treatment of Presbyopia-correcting IOLs and works by creating a single elongated focal point to enhance "range of vision" or "depth of focus."

Thereby, considering the growing demand for this product type, numerous new products are being launched in the market. For example, In May 2022, Ophtec BV introduced the Precizon Presbyopic Toric IOL. In November 2020, HumanOptics launched the trifocal posterior chamber IOL for presbyopia correction, TRIVA in Europe. In September 2019, BVI®, through its PhysIOL subsidiary, launched FineVision Triumf- the first and only Trifocal EDOF IOL in the European market.

Therefore, considering the advantages associated with intraocular implants and their growing popularity, this product category is expected to generate considerable revenue thereby pushing the overall growth of the global ocular implants market during the forecast period.

North America is expected to dominate the overall Ocular Implants Market:

Among all the regions, North America held the largest share of 45.18% in 2022. This can be ascribed to the growing prevalence of eye disorders and refractive errors such as cataracts, glaucoma, myopia, presbyopia, and others.

As per the National Diabetics Statistics Report by the Centers for Disease Control and Prevention (CDC, 2020), about 34.2 million Americans had diabetes in 2020. The report further stated that approximately 88 million Americans showed pre-diabetes levels. The CDC considers diabetes to be one of the major risk factors that may lead to glaucoma development.

In addition, according to the National Eye Institute, 2020, the United States recorded 7.7 million diabetic retinopathy cases and 24 million cataract cases in 2020, and it is expected to reach 11.3 million and 38 million, respectively, by 2030.

A cataract is the major cause of visual impairment, and geriatric ocular issues have been emerging as potential factors in the past few years in developing countries.

All the above-stated ophthalmic issues will require ocular implants at some point, for their correction, which is expected to increase the demand for ocular implants.

In addition to a large patient pool associated with refractive errors in the North American region, high consumer awareness, new market launches, and the presence of a highly potent market in terms of product development are also some key factors driving the growth of the North American ocular implants market. For instance, in July 2020, the United States Food and Drug Administration approved Allergan's drug-releasing implant, DURYSTA, for administration within the cavities of the eye to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Therefore, the above-mentioned factors are going to bolster the North America ocular implant markets.

Ocular Implants Market Key Players:

Some of the key market players operating in the Ocular Implants market include Alcon, Johnson & Johnson Services Inc., Bausch Health Companies Inc., ZEISS International, Glaukos Corporation, AbbVie Inc., MORCHER® GmbH, HumanOptics Holding AG, Alimera Sciences, Advanced Artificial Eyes, Erickson Laboratories, Midwest Eye Laboratories, Inc., EyeYon, EyePoint Pharmaceuticals, Inc., HOYA Corporation, SMR Ophthalmic Pvt. Ltd, Gulden Ophthalmics, AJL Ophthalmic S.A., KeraMed, Inc., Innovia Medical, and others.

Recent Developmental Activities in the Ocular Implants Market:

In April 2022, STAAR SURGICAL announced the launch of the EVO Vision Implantable Collamer Lens at the American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in Washington D.C.

In November 2022, Alcon Inc. took over Invantis Inc., which specializes in glaucoma ocular devices that are micro-invasive, in California to expand its glaucoma surgical implants segment.

In May 2020, Bausch+Lomb, a part of Bosch Health Companies Inc., announced the European launch of LuxSmart and LuxGood Preloaded Intraocular lenses. Some of the features of these lenses are their monofocal periphery, acrylic hydrophobicity along with UV light protection.

Key Takeaways from the Ocular Implants Market Report Study

Market size analysis for current ocular implants market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ocular implant market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years.

Key companies dominating the global ocular implants market.

Various opportunities available for the other competitor in the ocular implants market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current ocular implants market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for ocular implant market growth in the coming future?

Target Audience who can be benefited from this Ocular Implants Market Report Study

Ocular Implants providers

Research organizations and consulting companies

Ocular Implants -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in ocular implants

Various end users who want to know more about the ocular implants market and the latest technological developments in the ocular implants market.

Frequently Asked Questions for the Ocular Implants Market:

1. What are ocular implants?

Ocular implants are small devices designed to be inserted into the eye, made of medical-grade plastic acrylic. Ocular implants form a part of surgical procedures that help in the fixation of cataracts and other vision impairments such as glaucoma, presbyopia, myopia, etc.

2. What is the market for global ocular implants?

The global ocular implants market was valued at USD 5,060.43 million in 2023, growing at a CAGR of 4.51% during the forecast period from 2024 to 2030 to reach USD 6,561.46 million by 2030.

3. What are the drivers for the global ocular implants market?

The ocular implants market is expected to grow significantly owing to factors such as a rise in the prevalence of eye disorders such as cataracts, glaucoma, presbyopia, myopia, and others coupled with a rising geriatric population globally. The rapidly growing technological advancements taking place in the ocular implants market with better technologies for delivering safe and biocompatible implants are further expected to result in appreciable revenue growth in the ocular implants market during the given forecast period (2024-2030).

4. Who are the key players operating in the global ocular implants market?

Some of the key market players operating in the ocular implants market include Alcon, Johnson & Johnson Services Inc., Bausch Health Companies Inc., ZEISS International, Glaukos Corporation, AbbVie Inc., MORCHER® GmbH, HumanOptics Holding AG, Alimera Sciences, Advanced Artificial Eyes, Erickson Laboratories, Midwest Eye Laboratories, Inc., EyeYon, EyePoint Pharmaceuticals, Inc., HOYA Corporation, SMR Ophthalmic Pvt. Ltd, Gulden Ophthalmics, AJL Ophthalmic S.A., KeraMed, Inc., Innovia Medical, and others.

5. Which region has the highest share in the ocular implants market?

North America is expected to dominate the overall ocular implants market during the forecast period, 2024 to 2030. This can be ascribed to the presence of a large number of cases having eye disorders such as glaucoma, cataract, presbyopia, and myopia along with the rising geriatric population in the region. In addition, it is a highly potent market in terms of technological developments and launches along with the presence of key market players among other factors in the region.

Table of Contents

1. Ocular Implants Market Report Introduction

2. Ocular Implants Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Ocular Implants Market Key Factors Analysis

  • 4.1. Ocular Implants Market Drivers
    • 4.1.1. Rise in the cases of eye disorders like cataracts, glaucoma, presbyopia, and myopia
    • 4.1.2. The escalating burden of the geriatric population globally
    • 4.1.3. Technological advancements in product design
  • 4.2. Ocular Implants Market Restraints and Challenges
    • 4.2.1. Complications associated with surgical procedures and devices
    • 4.2.2. Lack of coverage of the premium lens
  • 4.3. Ocular Implants Market Opportunities
    • 4.3.1. Improving Product safety and biocompatibility
    • 4.3.2. Rising development of advanced ocular implants

5. Ocular Implants Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Ocular Implants Market

7. Ocular Implants Market Layout

  • 7.1. By Type:
    • 7.1.1. Intraocular lenses
    • 7.1.2. Corneal Implants
    • 7.1.3. Glaucoma Implants
    • 7.1.4. Artificial Iris
    • 7.1.5. Others
  • 7.2. By Material
    • 7.2.1. Biodegradable
    • 7.2.2. Non-biodegradable
  • 7.3. By Application
    • 7.3.1. Cataract
    • 7.3.2. Glaucoma Surgery
    • 7.3.3. Oculoplasty
    • 7.3.4. Drug Delivery
    • 7.3.5. Macular Degeneration
    • 7.3.6. Others
  • 7.4 By End User
    • 7.4.1. Hospitals
    • 7.4.2. Eye Speciality Clinics
    • 7.4.3. Ambulatory Surgical Centres
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Ocular Implants Market in USD million (2021-2030)
      • 7.5.1.2. Canada Ocular Implants Market in USD million (2021-2030)
      • 7.5.1.3. Mexico Ocular Implants Market in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Ocular Implants Market in USD million (2021-2030)
      • 7.5.2.2. Germany Ocular Implants Market in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Ocular Implants Market in USD million (2021-2030)
      • 7.5.2.4. Italy Ocular Implants Market in USD million (2021-2030)
      • 7.5.2.5. Spain Ocular Implants Market in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Ocular Implants Market in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Ocular Implants Market in USD million (2021-2030)
      • 7.5.3.2. Japan Ocular Implants Market in USD million (2021-2030)
      • 7.5.3.3. India Ocular Implants Market in USD million (2021-2030)
      • 7.5.3.4. Australia Ocular Implants Market in USD million (2021-2030)
      • 7.5.3.5. South Korea Ocular Implants Market in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia Pacific Ocular Implants Market in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Ocular Implants Market in USD million (2021-2030)
      • 7.5.4.2. Africa Ocular Implants Market in USD million (2021-2030)
      • 7.5.4.3. South America Ocular Implants Market in USD million (2021-2030)

8. Ocular Implants Market Company and Product Profiles

  • 8.1. Alcon
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Johnson & Johnson Services Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Bausch Health Companies Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. ZEISS International
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Glaukos Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. AbbVie Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. MORCHER® GmbH
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. HumanOptics Holding AG
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Alimera Sciences
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Advanced Artificial Eyes
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Erickson Laboratories
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Midwest Eye Laboratories, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. EyeYon
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. EyePoint Pharmaceuticals, Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. HOYA Corporation
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. SMR Ophthalmic Pvt. Ltd.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Gulden Ophthalmics
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. AJL Ophthalmic S.A.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. KeraMed, Inc.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Innovia Medical
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us